⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2336640 | 0.67 | — | — | |
| SCHEMBL8811707 | 0.61 | MAOA (0.47) | — | |
| SCHEMBL37684 | 0.58 | — | — | |
| SCHEMBL8832603 | 0.53 | TSHR (0.47) | — | |
| SCHEMBL9439689 | 0.53 | TSHR (0.47) | — | |
| SCHEMBL20278839 | 0.53 | TSHR (0.47) | — | |
| SCHEMBL15066 | 0.53 | — | — | |
| SCHEMBL13324558 | 0.53 | TSHR (0.47) | — | |
| SCHEMBL702562 | 0.51 | — | — | |
| SCHEMBL8984924 | 0.51 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20150361063-A1 | TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK | 2015-12-17 | — | — | US | disclosed |
| EP-2787990-A1 | TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION | Brandeis University (US) | 2014-10-15 | — | — | EP | disclosed |
| US-20140288145-A1 | TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION | BRANDEIS UNIVERSITY (US) | 2014-09-25 | — | — | US | disclosed |
| WO-2013085877-A1 | TREATMENT OF AMYLOIDOSIS BY COMPOUNDS THAT REGULATE RETROMER STABILIZATION | BRANDEIS UNIVERSITY (US) | 2013-06-13 | — | — | WO | disclosed |
| WO-2013036684-A1 | COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS | SATORI PHARMACEUTICALS, INC (US) | 2013-03-14 | — | — | WO | disclosed |
| WO-2013036665-A1 | COMPOUNDS FOR USE IN TREATING NEURODEGENERATIVE DISORDERS, SYNTHESIS THEREOF, AND INTERMEDIATES THERETO | SATORI PHARMACEUTICALS, INC. (US) | 2013-03-14 | — | — | WO | disclosed |
| US-20130060019-A1 | Compounds for Use in Treating Neurodegenerative Disorders, Synthesis Thereof, and Intermediates Thereto | SATORI PHARMACEUTICALS, INC. (US) | 2013-03-07 | — | — | US | disclosed |
| US-20130060013-A1 | Compounds useful for treating neurodegenerative disorders | SATORI PHARMACEUTICALS, INC. (US) | 2013-03-07 | — | — | US | disclosed |
| EP-2542085-A1 | COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS | Satori Pharmaceuticals, Inc. (US) | 2013-01-09 | — | — | EP | disclosed |
| US-20110251379-A1 | COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS | SATORI PHARMACEUTICALS, INC. (US) | 2011-10-13 | — | — | US | disclosed |
| WO-2011109657-A1 | COMPOUNDS USEFUL FOR TREATING NEURODEGENERATIVE DISORDERS | SATORI PHARMACEUTICALS, INC. (US) | 2011-09-09 | — | — | WO | disclosed |